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Abstract 
Chronic obstructive pulmonary disease (COPD) is an umbrella term used to indicate 
chronic bronchitis, emphysema, or a mixture of the two. Affecting over 10 million people 
and currently the 4th leading cause of death in the United States, COPD is prevalent 
amongst many aging individuals, with the severity of symptoms worsening over time1. To 
date, there is very little knowledge of COPD mechanisms and treatment methods. A 
decrease in laminin production, a key component of extra cellular matrices (ECMs), has 
been correlated with a decrease in lung function. We aimed to study the potential of lung 
ECMs modified to output increased laminin, namely lama3 and lama4, to reset older 
lung ECM to a younger state. To achieve this, we utilized modified muscular thin films 
(MTFs) with human lung fibroblasts (HLFs) that we called pulmonary thin films (PTFs). 
Stress in the cell monolayer of the PTF due to contraction, one key measure of 
pulmonary tissue function, causes the construct to bend. From this, the resulting 
contractile force can be derived due to known mechanical properties of PDMS, thickness 
of PTFs, and the radius of the curved beam upon contraction.  
First, we used microcontact printing of the modified ECMs on the PTFs. Then, after 
experiencing difficulty seeding on the substrate using microcontact printing, we 
employed a microfluidic deposition method with genipin to increase ECM adherence to 
the polydimethylsiloxane (PDMS) substrate. While we were able to successfully 
fabricate, seed HLFs, and experiment on PTFs using fibronectin with both microcontact 
printing and the deposition method, we were unable to seed cells with the correct line 
pattern using either method. These results pushed us to try a different method to 
evaluate the force output of HLFs on our modified ECMs – Traction force microscopy 
(TFM).  
TFM utilizes experimentally observed ECM displacements via a fluorescent microbead 
laden substrate to calculate traction force vectors generated at the surface of a cell. 
Furthermore, force production is a key measure not only of HLF function, but pulmonary 
tissue function as well. We found that the HLF came in two different morphology 
categories – spindle and non-spindle. When analyzing data of both morphologies 
collectively, little was found with regards to the ECMs influence on cell force output. 
However, when analyzing the morphologies separately, the spindle morphology followed 
the trend hypothesized – the increased laminin output in older ECMs increased the 
traction force output of HLFs causing them to be statistically different from their non-
modified, old control comparison. To this end, our data suggested that increased laminin 
output displayed the potential to return normal, young function to old lung ECM and may 
be key in future therapy methods for combatting ailments suffered by patients with 
COPD.  
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Chapter 1. Introduction 
Chronic obstructive pulmonary disease (COPD) is an umbrella term used to indicate 
chronic bronchitis, emphysema, or a mixture of the two. Affecting over 10 million people 
and currently the 4th leading cause of death in the United States, COPD is prevalent 
amongst many aging individuals, with the severity of symptoms worsening over time1. 
These symptoms include general reduced lung function (causing difficulty in breathing), 
damage to air sacs that may impair small airways within the lungs leading to difficulty in 
expelling air from one’s lungs and subsequent shortness of breath, increased cough and 
mucus production caused by consequent inflammation of these airways, and lessened 
oxygen delivered to the blood and subsequent vital organs within the human body2–7. 
More specifically, COPD entails a loss of alveolar septal segmentation resulting in 
enlarged airsacs, incurring a loss of surface area for gas exchange as well as capillary 
deterioration in the distal part of the lung coupled with subepithelial fibrosis resulting in 
further reduced airflow and lasting low oxygen levels in alveoli. Patient outcomes are 
worsened by the fact that there is an insufficient amount of knowledge of both COPD 
mechanisms and treatment methods. These circumstances give rise for the potential to 
markedly improve COPD patient wellbeing through rejuvenation therapy methods, 
namely by “resetting” the older lung ECM to a younger state to help remedy ailments, 
helping stabilize existing symptoms, and extending overall patient longevity. 
Substantial research has both shown that normal lung function is lost in COPD and with 
age, as well as posited the benefit of younger ECMs in comparison to older ECMs. It has 
been established in other organs that younger ECMs provide a long list of benefits - 
enhanced mechanical and biological properties, more efficient remodeling, and greater 
limits in cell proliferation in regards to decellularized kidneys in specific8–10. It has also 
been shown that ECM exposed to aged marrow cells exhibits reduced functionality in 
self-renewal and bone formation capacity11. Lastly, aged rodent lungs demonstrate both 
correlative changes in notable ECM proteins as well as increased sensitivity to fibrotic 
injury12–15.  
Found in ECM, laminins are trimeric molecules with alpha, beta, and gamma subunits 
that have provided notable insight into restoring ECM with key functions lost due to old 
age. Previous work has shown that laminins have the potential to modify older lung ECM 
to revert it back to a younger state16. For this experiment, two specific laminins are of 
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interest – lama3 and lama4. Lama4 is sourced from mesenchymal and endothelial cells, 
while Lama3 comes from epithelium17. In looking at each laminin individually, Lama4 has 
demonstrated the capacity to downregulate platelet-derived growth factor (PDGF) 
receptor, which has been linked in signaling increasing collagen deposition in fibrosis18. 
Also, lama4 deficiency is linked to both destabilized vasculature19 and lung ECM 
composition of idiopathic pulmonary fibrosis patients20. Lama3 has been found to be 
decreased in aged lungs and is structurally related to lama4, although it comes mainly 
from the epithelium17. Lastly, human bronchial epithelial cells display reduced expression 
of lama3 in aged matrix in comparison to young lung matrix and a large, positive 
correlation has been drawn between loss of lama3 and mechanical injury in mice21. 
Previous work has also demonstrated the effect of old age on lama3 and lama4 
together. Strong correlations have been drawn between lama3 and lama4 expression in 
relation to the age of their corresponding lung tissue. That is, in three-month-old lungs, 
lama3 and lama4 were observed to have remained stable, while in one-year-old lungs, 
both laminins were found to have drastically reduced compared to their younger state. 
Additionally, normal human fibroblasts cultured in decellularized, ventilated lungs of 
aged mice exhibited markedly reduced expression of lama4 in comparison to when they 
were cultured in young lung matrix22. 
The mechanism behind ECM induced loss of function of pulmonary cells by aging ECM 
is still unknown. Mesenchymal stem cell (MSC) ECM transfection provides a method for 
modifying cells to produce ECM with increased lama3 and lama4 output. Consequently, 
the relation between aging ECM and reduced laminin output can be explored as a 
possible solution for restoring aged-induced loss of function to lung cells. 
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Chapter 2. Evaluating the Role of Laminin Output in 
Extracellular Matrix Composition Using MTFs and 
Modified Lung ECM 
Chapter 2.1: PTF Background 
Muscular thin film (MTF) contraction assays provide a feasible approach for assessing 
the function and performance of human lung fibroblasts (HLFs) when modifying ECMs 
with lama3 and lama4. The MTF is a two-layer biohybrid construct consisting of a HLFs 
patterned via microcontact printing (CP) of extracellular matrix on a 
polydimethylsiloxane (PDMS) substrate. Stress in the cell layer due to contraction, one 
key measure of pulmonary tissue function, causes the construct to bend. From this, the 
resulting contractile force can be derived due to known mechanical properties of PDMS, 
thickness of MTFs, and the radius of the curved beam upon contraction. Specifically, for 
our experiments, MTFs will be denoted as pulmonary thin films (PTFs). In past work, 
MTFs have been employed in studying acute mechanical and biochemical dynamics of 
vascular smooth muscle cells23, as well as cardiomyocytes24 and valve endothelial 
cells25. This same method can be utilized to assess the difference in contraction of HLFs 
on lama3 and lama4 unmodified and modified ECMs. To this end, we hypothesized that 
that the fibroblasts exposed to aged ECM will exhibit lower contractile force than those 
exposed to Lama3 and/or Lama4-replete aged ECM consistent with data expressed 
above. 
Chapter 2.2: PTF Methods 
2.2.1 Cell Culturing and Seeding 
Rat-tail fibroblast (3T3) cells and HLFs were isolated and sourced from the NIH and the 
Mortari Lab, respectively. Both cells were cultured and seeded in the same fashion. 
Cells were grown in DMEM complete media with 10% FBS and 5% Pen-Strep. The 
media for cells was incubated at 37 C and exchanged every 48 hours until use. The 
cells were mobilized by aspirating media, rinsing with PBS, and then soaked in trypsin 
for 10 minutes. All microfluidic microcontact printed substrates were seeded at a density 
of 530,000 HLFs cm-2 to ensure confluent tissues. 
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2.2.2 MSC ECM Transfection 
All ECMS were provided by the Mortari lab, who decellularized, homogenized, then 
lyophilized mouse lungs to produce them. Eight different ECMs were produced through 
transfection with laminin proteins – lama3 and lama4. These groups can be seen in 
Figure 2.1a. For early work and comparison, fibronectin was used as well. 
2.2.3 Microcontact Printed Substrate and PTF Fabrication 
First, 25mm glass coverslips were sonicated for 30 minutes. PDMS was prepared by 
combining Sylgard 184 Silicone Elastomer Base with Sylgard 184 Silicone Elastomer 
Curing Agent in a 10:1 ratio along with 300 L of fluorescent bead solution (FluoSpheres 
carboxylate-modified, 1.0 m, nile red - 535/575), then mixing and degassing with an 
AR-100 ThinkyMixer. After preparing the PDMS, a strip of poly(n-isopropylacrylamide) 
(PIPAAM) was spincoated down the center of the coverslip by covering both sides with a 
piece of tape at a max speed of 6000 rpm for 35 seconds. Then, the two pieces of tape 
were removed and the PDMS was layered on top and spincoated at a max speed of 
4500 rpm for 60 seconds (Figure 2.2a). Finally, the coverslips were cured at 80 C for 4 
hours. 
2.2.4 Microcontact Printing (CP) 
Stamps with microscale features were fabricated using traditional photolithographic 
techniques. Photomask films were designed with alternating lines of 10 m width and 10 
m pitch. The photomasks were used to selectively expose SU8-3025 photoresist spin 
coated onto silicon wafers with a feature height of 5 m. Stamps were created by 
pouring PDMS onto the corresponding patterned silicon wafers. After degassing for one 
hour, PDMS was cured at 80 C for 4 hours. The stamps were then cut from the 
resulting wafer into appropriate shapes for use. 
Desired ECMs (either fibronectin or lung ECMs) were thawed to stamp and diluted to a 
concentration of 50 g*mL-1. 200-400 L of ECM was pipetted onto each stamp (200 L 
for fibronectin, 400 L for lung ECMs) and allowed to sit for 1 hour. After, the devices 
were air dried and previously fabricated PTFs were placed in the UVO for 8 minutes. 
Following UVO surface treatment, devices were sealed onto PDMS-coated PTFs via 
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conformal contact. The ECM-stamped PTFs were then placed in their own well, seeded 
at a density of 530,000 HLFs cm-2 and incubated for 24 hours in media (Figure 2.3a).  
2.2.5 Microfluidic Deposition Method 
Inspired by previous work done by Eric Hald26, microfluidic devices were fabricated using 
the same methods as microcontact printing stamps, but used a modified photomask film 
with branching channels and SU-8 photoresist with 25 micron feature height. Starting as 
a single channel, the pattern branched in a binary fashion until channels of 10 m width 
were separated by walls of 10 m width, generating the same pattern as the 
microcontact printing stamps. 
After punching 2 mm holes at the inlet and outlet of the microfluidic deposition stamps, 
100 L of 70% ethanol were pipetted at the inlet and let “wick” through the channels for 
5-10 minutes, or until the ethanol has entered the channels. Then, the microfluidic 
devices were rinsed with 100 L of 1X PBS by pipetting the PBS at the inlet and 
vacuuming at the outlet to pull the liquid through the channels. To deliver only ECM, 100 
L of the desired ECM (fibronectin or lung ECM) at a concentration of 50 g*mL-1 was 
pipetted at the inlet and pulled through with the vacuum again. When the ECM solution 
supply at the inlet began to go down the inlet, vacuuming was stopped and both ends 
were capped with 50 L of ECM to prevent drying out of the channels. The constructs 
were then placed in the incubator for 24 hours for the ECM to adhere to the PDMS 
substrate (Figure 2.3a). To deliver ECM and genipin, prior to administering the ECM, 
genipin was placed at the inlet and drawn through the device, 1X PBS was placed at 
both the inlet and outlets, and the genipin was incubated at 37 C for 4 hours. After 
incubation, 1X PBS was drawn through the device to remove excess genipin, and the 
desired ECM was drawn through the device using the same procedure as listed above, 
followed by incubation at 37 C for 24 hours (Figure 2.3b). After incubation, the 
microfluidic flow stamps were peeled off of the PTFs, the PTFs were rinsed with PBS, 
seeded at a density of 530,000 HLFs cm-2 and incubated for 12-16 hours.  
2.2.6 PTF Contractility Assay 
After waiting 12-16 hours from the point of seeding each construct, the PTFs were taken 
from their respective wells and placed in a 35 mm petri dish with warm Tyrode’s Solution 
(1.192g HEPES, .901g glucose, .265g CaCl2, .203g MgCl2., 4.03g KCl, 7.889g NaCl, 
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and .040g NaH2PO4 per liter of ddH2O). Using the Lumar V12 stereomicroscope (Carl 
Zeiss) to observe, 2 cuts were made vertically down the section of PIPAAM and the 
middle strip was peeled off uncovering a bare section. Then, multiple, parallel horizontal 
cuts were performed, and sections were peeled off in between the cuts to isolate strips 
to display contractile forces. The isolated horizontal strips remaining were gently lifted to 
allow Tyrode’s solution to go underneath them to dissolve the remaining PIPAAM below 
to allow them to contract freely. Once the strips exhibited proper contractility in the petri 
dish, the experiment was started with brightfield and fluorescent exposures at 1 second 
and 17.5 seconds, respectively. Images were taken every 30 seconds for a total duration 
of 60 minutes. HA-1077 Rho Kinase Inhibitor (ROCK) was administered at 5 minutes to 
inhibit contractility within the strips and induce a relaxed state for comparison later on 
(Figure 2.4a-b). 
2.2.7 Mechanical Analysis of PTF Bending 
Tissue stress in PTFs during the contractility assays was analyzed using a custom 
MATLAB code built upon previously reported methods24,27. Using the relaxed-state 
lengths in relation to the contracted-state lengths, a radius of curvature was derived in 
each PTF as in Grosberg et al.27. Then, the mean cross-sectional stress was calculated 
from the assessed radius of curvature and known thickness and stiffness of the tissue 
and PDMS layers as seen in Alford et al.24 (Figure 2.5a). 
Chapter 2.3 PTF Results 
2.3.1 PTF Microcontact Printing with 3T3 Cells  
2.3.1.1 PTF Cut Analysis 
To learn the procedure and develop the mechanical skills necessary to conduct the PTF 
contractility assay, 3T3 cells were used due to their accessibility, cost-effectiveness, and 
known immortality as a cell line. A focus was first placed on making concise cuts that left 
the freed strips of cell-coated PDMS to be as uniform as possible (Figure 2.6a).  
2.3.1.2 PTF Fluorescent Bead Imaging Assay 
Fluorescent bead density influences PTF imaging quality. To determine the correct 
volume of fluorescent beads to add to the PDMS solution, varying volumes of 
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fluorescent beads were added. The contrast in too few beads versus the correct amount 
beads yielding proper fluorescence was evident (Figure 2.6b). 
2.3.1.3 PTF Tissue Thickness 
PDMS layer thickness influences the force required to contract the PDMS strips and is 
controlled by the speed in which the PDMS is spincoated when fabricating the PTFs. By 
increasing the spin speed from 4500 to 7000 of the PDMS fabrication phase when 
creating the PTFs, the thickness of the PDMS was reduced. As a result, the necessary 
force to effectively produce a noticeable contractile effect was reduced as well. This 
resulted in some observable contractile effect (Figure 2.6c).  
2.3.1.4 PTF Seeding Density Assay 
The PTF calculations assume a confluent monolayer of cells. Therefore, it is imperative 
that the constructs are not under seeded. Because of this, an assay was run varying the 
amount of 3T3 cells seeded on PTFs to determine the appropriate seeding density 
(Figure 2.7a). It was finally determined that roughly 750,000 cells was the ideal number 
to seed with (a seeding density of 530,000 HLFs cm-2) which can be seen in the 
confluent layer of cells in (Figure 2.7b). With the proper seeding density and experiment 
technique mastered, a proper experiment was conducted with a fully confluent 
monolayer of cells and easily observable contractility in PDMS strips (Figure 2.7c). 
2.3.2 PTF Microcontact Printing with HLF Cells and Lung ECM 
After successfully conducting the experiment with 3T3 cells and fibronectin, tests were 
run using the 8 mouse lung ECMs and human lung fibroblasts (HLFs) acquired from the 
Mortari lab. Initial PTF tests with the new ECM were inadequate due to unaligned cell 
seeding orientations. To confirm that it was the ECM and not the HLFs, microcontact 
printing tests were run with the lung ECM with both 3T3s and HLFs as well as fibronectin 
with both 3T3s and HLFs. The lung ECM yielded poor results with both cell types, 
whereas fibronectin proved to effective with both cell types (Figure 2.8a).  
2.3.3 PTF Deposition Method 
Due to the difficulty with microcontact printing on the lung ECM, a different, patterning 
method was employed – microfluidic deposition. While the reasoning behind the 
complications in microcontact printing on the new lung ECM was still unclear, the 
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increased duration of time for ECM adhesion utilized in microfluidic deposition in 
comparison to microcontact printing provided promise in this new technique.  
2.3.3.1 Microfluidic Deposition Device Channel Assay 
To ensure that the channels were functioning properly, food coloring was mixed with 
PBS and ran through the microfluidic devices (Figure 2.9a). It was evident that the 
original wafer used to produce the microfluidic devices was worn from years of use seen 
by the many channels without food coloring in them. Additionally, the cells seeded using 
this were misaligned and non-confluent (Figure 2.9b). A new wafer with the same 
dimensions was produced, new stamps were produced from the wafer, and the same 
food coloring assay was run again (Figure 2.9c). While the microfluidic devices produced 
from the new wafer had much more functional channels, the cells seeded with this 
method were not aligning themselves into the line pattern produced on the microfluidic 
devices. 
2.3.3.2 Microfluidic Deposition with Varying Conditions 
To test whether altering the ECM conditions could improve cell adhesion outcomes, 
more trials were conducted with the microfluidic deposition devices fabricated from the 
new wafer, both with the original concentration of ECM, as well as with increased 
concentrations of ECM drawn through the microfluidic channels. The results yielded 
consistent results with prior trials – the cells did not produce the line pattern given on the 
microfluidic devices (Figure 2.10a). As a positive check, the deposition method was 
performed with fibronectin and HLFs instead of the lung ECM to prove that the method 
was feasible (Figure 2.10b). To improve ECM adherence to the PDMS surface, genipin 
was utilized. Initial tests with genipin provided some promise, as portions of cells 
underneath the microfluidic device began to orient themselves in the line pattern 
properly (Figure 2.10c). However, a confluent layer of cells large enough to conduct an 
experiment on was never produced. Therefore, in conjunction with the genipin, 
concentrations of ECM were once again altered as well as ECM binding durations and 
ECM binding climate conditions (varied conditions seen in Figure 2.10d). After repeated 
attempts with these altered conditions, the results never improved. 
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Chapter 2.4: PTF Discussion 
It has been shown in previous work that hydroxyproline levels (the measure of 
collagen/fibrosis) increases with age while transcription levels of collagen decrease with 
age. Overall, this indicates that collagen deposition accumulates overtime. Moreover, 
both laminin production and elastin expression drastically decrease with age as well 
(Figure 2.11a-b)28. This suggests that older lung tissue contains a greater ratio of 
collagen to elastin. This ratio aligns well with previous work performed by Janssens et al. 
showing that physiological ageing of the lung is associated with dilation of alveoli, 
enlargement of airspaces, and decreased static elastic recoil of the lung29. Therefore, 
operationalizing contractile force output of HLF cells with modified and unmodified ECM 
provides the potential to compare ECMs differing in both age and laminin modification in 
relation to the adhered HLF cells functional capacity. Previous methods for assessing 
human lung cell functional capacity utilized traction force microscopy (TFM) in 
conjunction with differing ECM ages30, but did not demonstrate how tissue-scale 
functionality differs. Not to mention, they also did not use the novel, laminin-modified 
ECMs that we employ here.  
After many attempts, the issues presented by switching from fibronectin to the lung ECM 
acquired from the Mortari lab were never resolved. One major issue for the lung ECM 
was the known, high collagen content of the lung ECM. Previous work performed by Eric 
Hald has shown similar difficulty when utilizing collagen dense ECMs to create oriented 
lines on a PDMS substrate. Moreover, conversations with Pat Alford and Eric Hald have 
posited the difficulty of using this ECM in the past. The most established method for 
microcontact printing is to use fibronectin26. Due to its uniformity and more conducive 
microcontact printing properties, fibronectin provides a superior component not only for 
the cells to adhere, but also has the necessary properties for stamping. 
The deposition method did begin to generate promising results seen in the scattered, 
oriented lines of cells. However, the same issues occurred when using this method as 
well, as the cells bunched together in clusters, as opposed to adhering to the line pattern 
used by the microfluidic devices. Once again, the non-uniform “chunkiness” of the lung 
ECM came into question. The supernatant was used to rectify the chunkiness of the 
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ECM for it to freely flow and make contact uniformly along the surface of the PDMS 
when using the microfluidic device. However, this failed to rectify previous issues with 
producing an oriented sheet of cells. Finally, it is known that collagen is temperature-
sensitive and exhibits gelation at 25-37 C31. Reducing the incubation climate 
temperature of the ECM to 4 degrees Celsius from 37 degrees Celsius did not help 
either, even when allotting more time to compensate for reduced molecular kinetics 
based on the lower climate temperature.  
Chapter 2.5: PTF Conclusion 
Here, we report a method for studying HLF cell contractility in vitro under physiologically-
relevant conditions. While unsuccessful, because we were able to produce some results 
with cells adhering in the desired line orientation using the deposition method with 
genipin, we believe there is potential in this method, provided the appropriate testing 
conditions are found. Based on past work done by Yoshie et al. and Razafiarison et al., 
SULFO-SANPAH is a tested crosslinking compound that has been proven to be highly 
effective when working with collagen32,33. We believe that using this compound in a 
similar fashion to the method used with genipin could possibly alleviate the issues 
confronted in this research.  
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Chapter 3. Evaluating the Role of Laminin Output in 
Extracellular Matrix Composition Using TFM and 
Modified Lung ECM 
 
Chapter 3.1: TFM Background 
Traction force microscopy (TFM) assays provide a feasible approach for assessing the 
function and performance of lung tissue when modifying ECMS with lama3 and lama4. 
TFM utilizes experimentally observed ECM displacements via a fluorescent microbead 
laden substrate to calculate traction force vectors generated at the surface of a cell. 
Furthermore, force production is a key measure not only of HLF function, but pulmonary 
tissue function as well. In past work, TFM has been employed in work focused on the 
lungs, such as studying age-dependent stiffening in vessels and parenchymal tissue of 
lung cells30, as well as in evaluating the contractile response of alveolar epithelial cells to 
the inflammatory agonist thrombin34. It has also been used in other less-related areas, 
such as to investigate traction force generation as a biophysical marker of metastatic 
potential35. Thus, it is evident that quantitative assessment of single cells during culture 
is a reliable technique to gauge their respective levels of functionality. This same method 
can be utilized to assess the difference in contraction of HLFs on lama3 and lama4 
unmodified and modified ECMs. We hypothesized that the fibroblasts exposed to aged 
ECM will exhibit lower traction force than those exposed to Lama3 and/or Lama4-replete 
aged ECM consistent with data expressed above. 
Chapter 3.2: TFM Methods 
3.2.1 Cell Culturing and Seeding 
Rat-tail fibroblast (3T3) cells and human lung fibroblasts (HLFs) were isolated and 
sourced from the NIH and the Mortari Lab, respectively. Both cells were cultured and 
seeded in the same fashion. Cells were grown in DMEM complete media with 10% FBS 
and 5% Pen-Strep. The media for cells was incubated at 37 C and exchanged every 48 
hours until use. The cells were mobilized by aspirating media, rinsing with PBS, and then 
soaked in trypsin for 10 minutes. 
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3.2.2 MSC ECM Transfection 
All ECMS were provided by the Mortari lab, who decellularized, homogenized, then 
lyophilized mouse lungs to produce them. Eight different ECMs were produced through 
transfection with laminin proteins – lama3 and lama4 (Figure 3.1a). 
3.2.3 Construct Fabrication 
To be able to effectively visualize the polyacrylamide (PAA) substrate, 20 mm diameter 
through-holes were cut into 35 mm petri dishes using a laser cutter (150-Watt Universal 
PLS6.150D). Then, 25 mm glass coverslips were PDMS-adhered to the bottom of the 
laser-cut constructs and baked at 80 C for 4 hours (Figure 3.2a). PDMS was prepared 
by combining Sylgard 184 Silicone Elastomer Base with Sylgard 184 Silicone Elastomer 
Curing Agent in a 10:1 ratio, then mixing and degassing with an AR-100 ThinkyMixer. 
3.2.4 Polyacrylamide Substrate Fabrication 
To fabricate the PAA gel substrate, 13.5 kPa PAA stock solution was prepared from 40% 
acrylamide (Bio-Rad), bis-acrylamide (G-Biosciences), 10X PBS (10 mL), and DI Water 
(22.12 mL). Then, 2397 L of PAA stock solution was vortexed with 12.5 L of 
fluorescent beads (FluoSpheres, amine, .2m , red, 580/605) for 10 seconds, and 
vacuumed for 30 minutes. As the PAA stock solution was vacuumed, the constructs 
were prepared by rinsing with ethanol, air drying and then UVOed for 8 minutes. After 
the UVO was finished, 200 L of BIND Silane was pipetted onto the surface of the 
construct coverslips and a duration of 15 minutes was allowed for the BIND Silane to 
evaporate. Then, the constructs were rinsed 3 times with ethanol and air dried again.  
To make PAA substrate mixture, the post-vacuumed PAA stock solution was mixed with 
Tetryamethylethylenediamine (5 L), 1 M hydrochloric acid (35 L), acrylic acid N-
hydroxysuccinimide ester (25 L at 5mg*mL-1), and ammonium persulfate (APS) (12.5 
L). Immediately after mixing the components, 10 L of the mixed solution was pipetted 
onto the coverslip surface of the construct and a 15 mm coverslip was promptly placed 
on top to spread out the PAA mixture into a uniform sheet layer and let sit for 1 hour. 
After waiting one hour, the PAA gel sheet was hydrated with 2 mL of PBS for 30 
minutes. Then, the 15 mm coverslips were peeled off, the PAA gel was rinsed with 1X 
PBS, and 2 mL photoactivatable heterobifunctional reagent sulfosuccinimidyl 6 (4-azido-
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2-nitrophenyl-amino) hexanoate (Sulfo-SANPAH) was pipetted into each construct and 
UVOed for 10 minutes. After UVOing, the constructs were aspirated, rinsed with 1X 
PBS, and soaked with 2 mL Sulfo-SANPAH and UVOed one more time. The remaining 
Sulfo-SANPAH was aspirated, the constructs were rinsed one more time with 1X PBS, 
and 1 mL of each ECM (50mg/mL) was pipetted onto its own construct and incubated for 
3 hours. After incubating, the ECM was aspirated out, each construct was rinsed with 
PBS, and then seeded at a density of 1,500 HLFs*cm-2 (10,000 HLFs per construct). 
HLFs were allotted 12-16 hours to adhere before performing the TFM assay. 
3.2.5 TFM Assay of Polyacrylamide Substrate Constructs 
Experiments were performed on an Olympus X81 Inverted Microscope using a 40x 
UPLSA PO40X2, NA 0.95 objective in an environmental control chamber at 37 C. 
Images were acquired using MetaMorph software (Molecular Devices, Sunnyvale, CA) in 
the same media as described in section 3.1.1. Cells were given fresh media 60 minutes 
before data collection. Brightfield and TRITC fluorescent images were taken at exposure 
values of 10 and 100 ms, respectively, of both types of morphology categories, (spindle 
and non-spindle), in roughly even numbers for each ECM-related construct. Images 
were first taken of cells and the locations of each cell was saved. Then, the constructs 
were lysed using sodium dodecyl sulfate (SDS) and post-lysis fluorescent pictures were 
taken of the same locations to obtain pre and post-lysis pictures for comparison of cell-
generated traction forces. 
3.2.6 TFM Mechanical Analysis 
Images were analyzed using ImageJ. First, pre and post lysing pictures were stacked 
and aligned using a Template Matching ImageJ plugin. Particle image velocimetry using 
iterative interrogation windows of 128-64-32 pixel width was completed between the 
aforementioned stacked bead images from the same cell location. The noise-filtered 
displacement field was used to calculate traction stresses with a Fourier transform 
traction cytometry (FTTC) ImageJ plugin using the Fourier transform traction cytometry 
method36. Outputs from the FTTC ImageJ plugin were then analyzed using a custom 
MATLAB code built upon previously reported methods37 and total force magnitudes for 
single cells were calculated. Normalized force was calculated by dividing the total force 
by the area of the cell. 
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3.2.7 Statistical Methods  
All statistical analysis was performed using Sigma Plot software (San Jose, CA). 
Significant differences between groups for all experiments was estimated by one-way 
and two-way ANOVA with Dunn-Sidak and Tukey pairwise multiple comparisons post 
hoc tests. 
Chapter 3.3: TFM Results 
3.3.1 Overall Traction Force Produced by Cells 
We aimed to build upon previous findings suggesting that ECM replete with lama3 
and/or lama4 would renew older HLFs with their younger state functionality. To do this, 
we utilized custom-made TFM constructs and a Sulfo-SANPAH crosslinking compound 
to overcome previous issues with ECM adherence to substrates. TFM allowed us to 
assess single-cell traction forces on a substrate with a known Youngs Modulus (Figure 
3.3a). Tests were conducted on each ECM (A-H), allowing us to compare data across 
each modified ECM (ECM C-F) with the control, unmodified ECMs (A and B). In addition, 
average force trends were normalized by cell surface area to analyze the role cell size 
played in generating traction forces. 
First, we studied the effect of age on the overall average force generation of all HLFs. 
We found statistical significance between HLFs seeded on older ECM compared HLFs 
seeded on younger ECM (Figure 3.3b). When we normalized these values by the cell 
surface area, we found that averages leveled out. (Figure 3.3c). No statistical 
significance was reported for this trend. 
3.3.2 Overall Traction Force Based on Cell Morphology 
3.3.2.1 ECM Dependent Cell Morphology 
In our experiment, HLFs exhibited two morphologies that we characterized under two 
different categories – spindle and pleomorphic/spread out non-spindle (which will be 
called non-spindle in this paper) (Figure 3.4a-b). Prior to TFM experiments, brightfield 
images were taken of cells on each ECM at 10X magnification to quantify the ratio of 
each cell morphology based on the age of the ECM (Figure 3.4c). Our data suggests 
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that the age of the ECM does not influence the morphology type of the cell, as no 
statistical significance was found. 
3.3.2.2 Traction Force by Cell Morphology 
It was also observed that the generated traction force displacement differed based on 
the cell morphology (Figure 3.4d). Both morphologies were evaluated for their overall 
average force outputs as well as their overall average force outputs normalized by area. 
It is evident that the force distribution of non-spindle cells is much more spread out and 
random compared to spindle cells, leading to increased variability for traction force 
output. Statistical significance was found between spindle and non-spindle morphologies 
for non-normalized force outputs only. 
3.3.3 Traction Force by ECM Type 
Next, we studied the effect of ECM type on average force output, independent of 
morphology type (Figure 3.5a). For average forces not normalized by cell surface area, 
statistical significance was found between the following ECMs: control old and both 
empty vector young and lama4 old. No statistical significance was found when 
normalizing traction forces by cell surface area. 
3.3.4 Traction Force by ECM Type and Cell Morphology 
There were two categories of morphologies considered in this experiment – spindle and 
non-spindle (Figure 3.4a-b). Figure 3.6a shows the ratio of spindle to non-spindle 
morphologies counted based on each ECM type. Traction forces, both alone as well as 
normalized by cell surface area, were separated by both ECM type and morphology 
type. These values can be seen in Figure 3.6b and 3.6c, for spindle and non-spindle 
morphologies, respectively. For the ratio of spindle to non-spindle morphologies based 
on ECM type, statistical significance was found between lama4 and both empty vector 
and control ECMs. For spindle morphologies not normalized by area, statistical 
significance was found between the old control and young control, young lama3, old 
lama3, young lama4, and young empty vector. Additionally, statistical significance was 
found between old vs young ECMs as well as the control and lama3 ECMs. For spindle 
morphologies normalized by area, statistical significance was found between young 
control ECM and old lama3 ECM. For non-spindle morphologies, no statistical 
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significance was found between any ECMs for both normalized and non-normalized by 
cell surface area samples.  
When comparing the old control ECM to the lama3 or lama4 modified ECMs, the data 
suggests that the increased laminin output of the modified ECMs does in fact return 
normal, young force output to the older ECMs for the non-normalized spindle 
morphology condition. However, these suggested trends are lost when normalizing the 
spindle morphology average forces by their respective cell surface areas seen in Figure 
3.6b. Moreover, the credibility of these trends is also marginalized due to the lack of 
statistical significance found between the young and old empty vector ECMs as well as 
the large variability seen generated outputs of cells, independent of their corresponding 
age and ECMs types.  
Chapter 3.4: TFM Discussion 
3.4.1 ECM Age Influences HLF Function 
It has been shown in previous work that hydroxyproline levels (the measure of 
collagen/fibrosis) increases with age while transcription levels of collagen decrease with 
age. Overall, this indicates that collagen deposition accumulates overtime. Moreover, 
both laminin production and elastin expression drastically decrease with age as well 
(Figure 3.7a-b)28. This suggests that older lung tissue contains a greater ratio of collagen 
to elastin. This ratio aligns well with previous work performed by Janssens et al. showing 
that physiological ageing of the lung is associated with dilation of alveoli, enlargement of 
airspaces, and decreased static elastic recoil of the lung29. Therefore, our work here in 
operationalizing contractile force output of HLFs with modified and unmodified ECM 
provides the potential to compare ECMs differing in both age and laminin modification in 
relation to the adhered HLFs functional capacity. The findings from Godin et al. align well 
with our results (Figure 3.3b) – HLFs seeded on older ECM produced lower contractile 
force than ones seeded on younger ECM. While statistical significance was not found 
due to high intersubject variability, the averages represent this trend. Conversely, Sicard 
et al. performed TFM on both young and old pulmonary artery smooth muscle cells 
(PASMCs) and found the opposite to be true – older cells generated more contractile 
force than their younger counterparts30. Similarly to our results, Sicard et al. also 
reported high intersubject variability. Additionally, their experiments focused on varying 
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the age of the source of PASMCs, as opposed to ours, where the cell age was kept 
consistent and the ECM age was varied. 
3.4.2 Morphology Influences HLF Function 
It was clear that there was another variable in play influencing the generated traction 
force recorded by the cells – the cell morphology or phenotype. There were two 
categories of cell morphologies considered in our research – spindle and non-spindle 
(Figure 3.4a-b). The traction force heat maps for the representative spindle and non-
spindle morphologies illustrate the disparity in how the traction forces are spread out for 
each morphology. The spindle morphology produced much more predictable traction 
force outputs than the non-spindle morphologies, due to their more consistent structure 
in comparison to the much more broadly encompassing non-spindle category. Non-
spindle morphologies generated a higher average force output than spindle cells (Figure 
3.4d). This is likely due to the larger cell surface area seen in the non-spindle 
morphology. When normalized by cell surface area, the values are much more 
consistent between morphology types (Figure 3.4d). Morphological influences on cell 
function in accordance with these findings are posited in other studies as well. Alford et 
al. elucidated the relationship between cell architecture and contractile output in vascular 
smooth muscle cells (VSMCs). More specifically, using controlled VSMC geometry on 
muscular thin films (MTFs), they demonstrated the difference in contractile force 
generated by the differing cell morphologies of VSMCs – spindle and pleomorphic38.  
Chapter 3.4.3 ECM Type Influences HLF Function 
We asked whether modification to increase expression of laminins, lama3 and lama4, in 
old ECM would revitalize HLFs to function similarly to their younger correspondents. To 
address this question, we first assessed the contractile force generated by the HLFs on 
each respective ECM (Figure 3.5a). The data suggests that the increased laminin 
expression in the old, modified ECMs is influencing the contractile behavior of the HLFs, 
illustrated by the comparison between the old, control ECM and the old lama3 and 
lama4 ECMs. However, this is confounded by the fact that the graphs consider both 
morphology types (Figure 3.5a). In relation, other work has displayed that cells are 
influenced by their corresponding ECM. Booth et al. compares cell function on both 
acellular human normal and fibrotic lungs to show how lung matrices influence the 
phenotype of exogenously added human lung fibroblasts. Fibroblasts in normal lung 
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ECM retained a known phenotype characterized by low -SMA production, while cells in 
the IPF lung ECM exhibited a significant increase in the production of -SMA, 
demonstrating the role ECM plays in cell function and phenotype20. 
Chapter 3.4.4 Modified ECMs Influence Aged HLF Function 
Due to the noticeable variance in average force output by the two cell morphologies in 
consideration, focusing on each individual morphology in conjunction with each ECM 
type provides the best picture of how the modified ECM was affecting HLF functionality 
(Figure 3.6b-c) While little statistical significance is reported in the non-spindle 
morphology (Figure 3.6c), the spindle morphology data suggests the trend hypothesized 
in this paper -the increased laminin expression seen in the modified ECMs provides the 
potential to renew old ECMs with their younger contractility through the increase in force 
output of HLFs seen on laminin-modified, old ECM for spindle cells (Figure 3.6b). When 
normalized by the area, many of the trends shown in the non-normalized spindle cell 
force output (Figure 3.6b) are lost. It was observed that there was not a direct correlation 
between cell size and force output for cells, even when separating by morphology. 
Additionally, no correlations were drawn for average force output by non-spindle 
morphologies, most likely due to the wide variance in structures considered within this 
category.  
While the sample size for each cell morphology was kept roughly even when conducting 
TFM, the modified ECMs incurred a marked jump in the number of spindle cells in 
relation to the non-spindle cells from the non-modified ECMs taken in the brightfield 
pictures prior to each experiment (Figure 3.6a). The relevance of this to the overall 
hypothesis of the paper is unknown, as the focus of each TFM experiment was placed 
on finding significant differences between each ECM based on the morphology type. 
However, in accordance with our work, studies by Unemori et al. demonstrate that cell 
phenotypes can be altered based on the constituents of their surrounding environment 
or ECM. Moreover, Unemori et al. showed that by administering relaxin to HLFs, ECM 
matrix deposition (namely collagen types I and III) and subsequent lung fibrosis was 
inhibited39. 
In a similar fashion, our research posits the potential benefit in increasing ECM laminin 
expression to combat the loss of lung functionality observed in COPD patients. As they 
have been previously described above, laminins are key components of basement 
30 
 
membranes, which separate parenchymal cells from adjacent connective tissue. 
Specifically, laminins play important roles in tissue morphogenesis and homeostasis by 
regulating tissue architecture, cell adhesion, migration, and matrix-mediated signaling21. 
Studies performed by Schuger et al. established the importance of laminin expression 
and the ability of lung cells in culture to reproduce normal tissue patterns. Schuger et al. 
demonstrated that laminin influence on morphogenic epithelial-mesenchymal 
interactions is not restricted to a particular stage of lung development40. To this end, the 
critical role laminins play for lungs in maintaining functional capacity at an older age is 
evident.  
Chapter 3.5: TFM Conclusion 
Here, we report a method for studying HLF contractility in vitro under physiologically-
relevant conditions. We tested lung functionality by comparing the traction forces for 
HLFs on PAA substrates laden with the varying ECMs. While the data suggests that the 
modification of increased laminin expression returns younger functionality to the HLFs 
through the increase in traction force exhibited by the modified old ECMs in comparison 
with the control old ECM, the large variability in force output displayed by the cells 
coupled with the lack of a tissue-scale model provides a promising, yet incomplete 
illustration of what effect increased laminin expression in lung ECM could have at the 
patient level for COPD. Moving on, we recommend two possible avenues for building on 
this work: 1) using a micropatterning method similar to the one seen in Liu et al. that 
uses microcontact printing prior to TFM to decrease cell-based variance when 
conducting TFM experiments41; 2) employ MTF methods to garner a tissue-scale 
perspective on the influence the modified ECMs have on HLF function. 
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